U.S. Backs Roche Cervical Cancer Test

at risk of developing cervical cancer, the most frequent cancer in females after breast cancer. The U.S. Food and Drug Administration backed Roche's so-called cobas HPV test after reviewing clinical data involving some 47,000 women, who were tested for...